Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Roger's 1997 Short Picks -- Ignore unavailable to you. Want to Upgrade?

To: Pancho Villa who wrote (8134)	12/10/1997 10:48:00 PM
From: Bill Wexler	Read Replies (1) \| Respond to of 9285

The company was Schering-Plough...and it really isn't an issue. Take a look at the history of this company and male impotency drugs in general. I think this sector went through a mini-mania with Vivus. the realization is that these drugs have limited, if any efficacy and the market isn't anywhere near as large as was first touted. Check out all the positive news, licensing agreements, and analyst upgrades on Vivus. Right before it tanked. Zonagen is the weakest among the group and it is starting to smell of high scam. I can't stress this enough....short it and then short more.